Follow Us      

LOGIN
 
Share Page:
Back

Volume 39 , Issue 3
May/June 2019

Pages 361–368


Clinical Guidelines for Implant Treatment in Patients with Down Syndrome

Hugo De Bruyn, DDS, MSc, PhD/Maarten Glibert, DDS, MSc/Liesbet Matthijs, DDS, MSc/Martens Filip, DDS, MSc/Véronique Christiaens, DDS, MSc/Luc Marks, DDS, MSc, PhD


PMID: 29590223
DOI: 10.11607/prd.3284

This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2019 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help